Charlson Comorbidity Index

There are 1,226 papers on Charlson Comorbidity Index in aging research: 16 trials and 1,167 observational studies in people, 1 in animals, 32 reviews. The newest story, Nov 14, 2026: “Age and frailty linked to different intensive care outcomes”.

Biomarker

1,226 papers study it807 more mention it401 findings

73 new papers in 30 daysSee all 2,033 papers on Charlson Comorbidity Index

“A higher Charlson index correlated with a positive delta, while a negative delta correlated with a lower Charlson index (p=0.01).”
Handgrip Evaluation Before and After Pulmonary Rehabilitation Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD)Cureus2024doi:10.7759/cureus.69404
  • Human trial16
  • Humans1,167
  • Animals1
  • In silico4

Interventions

1

Diabetes control

downin humans1

1 study
  1. Diabetes control is linked with lower Charlson Comorbidity Index in humans (traditional concordant comorbidities in diabetes) (β = -0.951, P < 0.001).

    “Diabetes control was significantly associated with a decrease in both the numbers (β = -0.720; P < 0.001) and CCI of TCC (β = -0.951; P < 0.001)”

    Humanstraditional concordant comorbidities in diabetes

    Longitudinal insights into comorbidity patterns and burden among middle-aged and older adults with diabetes in China: a nine-year cohort study using CHARLS

    Journal of global health

More on Diabetes control

Effects

18

Mortality

no changein humans9upin humans1HR 1.089

10 studies
  1. Charlson Comorbidity Index was not clearly linked with mortality in humans (multivariable Cox model adjusting for age and other confounders in elderly AMI patients) (HR = 1.089).

    “CCI did not reach statistical significance after adjustment for age and other confounders (HR = 1.089, P = 0.125).”

    Humansmultivariable Cox model adjusting for age and other confounders in elderly AMI patientsmedian 40.9 monthsn = 350

    Charlson comorbidity Index for descriptive risk stratification of long-term All-cause mortality in elderly patients with acute myocardial infarction: a retrospective cohort study

    Frontiers in cardiovascular medicine

  2. Charlson Comorbidity Index was not clearly linked with mortality in humans (stratified by treatment).

    “CCI did not influence mortality when stratified by treatment.”

    Humansstratified by treatment72.7% females

    Impact of mitral valve intervention and frailty on outcomes of severe mitral regurgitation due to severe mitral annular calcification

    Progress in cardiovascular diseases

  3. Charlson Comorbidity Index is linked with higher mortality in humans (fragility fractures) (OR 0.44, p = 0.001).

    “while Charlson Comorbidity Index > 6 predicted higher mortality (OR 0.44; p = 0.001).”

    Humansfragility fracturesone yearn = 486

    Orthogeriatric co-management of fragility fractures: a retrospective cohort study on one-year mortality and functional outcomes across fracture types

    BMC geriatrics

  4. Charlson Comorbidity Index was not clearly linked with mortality in humans (COVID-19 diagnosis in nursing home residents) (base AUROC 0.61 (CI: 0.60 to 0.63)).

    “The addition of CCI did not improve these predictive performance measures.”

    HumansCOVID-19 diagnosis in nursing home residents28 daysn = 4,318

    Charlson comorbidity index has no incremental value for mortality risk prediction in nursing home residents with COVID-19 disease

    BMC geriatrics

  5. Charlson Comorbidity Index was not clearly linked with mortality in humans (systemic AL amyloidosis).

    “Comorbidity was also analyzed with the Charlson comorbidity index, but it did not reach statistical significance in the model.”

    Humanssystemic AL amyloidosisn = 416

    A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

    Cancers

  6. Charlson Comorbidity Index was not clearly linked with mortality in humans (intertrochanteric fractures) (survival rates 93.5% vs 86.2%).

    “Charlson comorbidities index maybe not the indicator of 2-year mortality in older patients with intertrochanteric fractures.”

    Humansintertrochanteric fractures2-yearn = 60

    Predictive value of Charlson comorbidity index and cofactors on 2-year mortality in older patients with intertrochanteric fractures: a retrospective analysis

    Preprint

  7. Charlson Comorbidity Index was not clearly linked with mortality in humans (acute hip fracture) (p = 0.172).

    “The Charlson Comorbidity Index did not correlate with mortality (p = 0.172).”

    Humansacute hip fracture

    Clinical data or scoring system for predicting mortality in elderly patients with hip fracture: A prospective study

    Injury

  8. Charlson Comorbidity Index was not clearly linked with mortality in humans (unilateral intertrochanteric fracture undergoing surgical treatment) (survival rates 93.5% vs 86.2%).

    “Charlson comorbidity index maybe not the indicator of 2-year mortality in older patients with intertrochanteric fractures.”

    Humansunilateral intertrochanteric fracture undergoing surgical treatment2-yearn = 60

    Relationship between Charlson comorbidity index, early recovery and 2-year mortality in elderly patients undergoing surgical treatment of inter-trochanteric fractures: a retrospective analysis

    Scientific reports

  9. Charlson Comorbidity Index was not clearly linked with mortality in humans (p > 0.05).

    “No correlation (p > 0.05) was found between mortality and ASA or Charlson score.”

    Humansn = 36

    Total Knee Arthroplasty in Octogenarians: Should We Still Be so Restrictive?

    Geriatrics (Basel, Switzerland)

  10. Charlson Comorbidity Index was not clearly linked with mortality in humans (proximal femoral fracture treated non-operatively) (42.8%).

    “The mortality rate in one year was 42.8% without statistical positive correlation with any of the studied parameters.”

    Humansproximal femoral fracture treated non-operativelyn = 28

    Factors associated with one year mortality in ill patients with proximal femoral fractures treated non operatively

    Injury

Survival

downin humans4

4 studies
  1. Charlson Comorbidity Index is linked with lower survival in humans (ovarian cancer).

    “Patients with higher CCI scores had significantly shorter survival, and CCI was identified as an independent prognostic factor in multivariate analysis.”

    Humansovarian cancerfemalesn = 130

    Evaluating Comorbidity Scores in Geriatric Ovarian Cancer: A Retrospective Cohort Analysis

    Medicina (Kaunas, Lithuania)

  2. Charlson Comorbidity Index is linked with lower survival in humans (p<0.001).

    “There were linear relationships between Clinical Frailty Scale (CFS) or Charlson Comorbidity Index (CCI) and diminished survival in the pooled data (both p<0.001).”

    Humans

    Cardio pulmonary resuscitation (CPR) in the frail and those with multiple health conditions: Outcomes before and during the COVID pandemic

    Clinical medicine (London, England)

  3. Charlson Comorbidity Index is linked with lower survival in humans (p < 0.0001).

    “Patient survival was significantly different between CCI groups at 1, 3, and 5 years, respectively: 90%, 88%, and 84% for group 1, 88%, 80%, and 72% for group 2, and 87%, 75%, and 63% for group 3 (p < 0.0001).”

    Humansn = 387

    Renal Transplantation in the Elderly: Are They All the Same? A Multicenter, Comorbidity-Based Study

    Nephron

  4. Charlson Comorbidity Index is linked with lower survival in-hospital cardiac arrest (ANOVA p<0.001).

    “A linear correlation has been identified between increasing CCI and reduced survival (ANOVA = p<0.001)”

    Humansin-hospital cardiac arrestn = 113

    Frailty, multimorbidity and in-hospital cardiopulmonary resuscitation: predictable markers of outcome?

    Clinical medicine (London, England)

Overall survival

downin humans1no changein humans1

2 studies
  1. Charlson Comorbidity Index is linked with lower overall survival in humans (peripheral T-cell lymphoma) (4.4 months vs 11.9 months (P < .001)).

    “Patients with a CCI > 1 had a worse median overall survival (4.4 months) compared with patients with CCI = 0 (11.9 months) and CCI = 1 (8.4 months; P < .001).”

    Humansperipheral T-cell lymphoman = 775

    Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients

    Blood advances

  2. Charlson Comorbidity Index was not clearly linked with overall survival in humans.

    “No association with OS was found for CCI (P=.46).”

    Humansn = 231

    Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy

    International journal of radiation oncology, biology, physics

Hospital-associated disability

no changein humans1OR 0.98

1 study
  1. Charlson Comorbidity Index was not clearly linked with hospital-associated disability in frail hospitalized older adults (CFS ≥5) (OR 0.98, 95% CI 0.90-1.06).

    “and was not observed in the frail group (OR, 0.98; 95% CI, 0.90-1.06).”

    Humansin frail hospitalized older adults (CFS ≥5)n = 1,299

    Comorbidity link to hospital disability fades with frailty

    Journal of the American Medical Directors Association

Poor recovery

no changein humans1OR 1

1 study
  1. Charlson Comorbidity Index was not clearly linked with poor recovery in humans (acute traumatic brain injury) (OR 1.00, 95% CI 0.76-1.32).

    “not with comorbidities (CCI OR 1.00, 95% CI 0.76-1.32)”

    Humansacute traumatic brain injury6 monthsn = 112

    Multidimensional Preinjury Health and 6-month Outcome After Traumatic Brain Injury in Older Adults Presenting With Mainly GCS 13-15

    The Journal of head trauma rehabilitation

Intrinsic capacity

no changein humans1

1 study
  1. Charlson Comorbidity Index was not clearly linked with intrinsic capacity in humans (controlling for age in multivariable analysis) (β = -0.036, 95% CI - 0.142 to 0.070, p = 0.505).

    “In multivariable analysis, CCI was not independently associated with preserved IC (β = -0.036, 95% CI - 0.142 to 0.070, p = 0.505)”

    Humanscontrolling for age in multivariable analysisfemalesn = 200

    Intrinsic capacity and comorbidity burden capture distinct but age-driven dimensions of health in older postmenopausal women

    Aging clinical and experimental research

More on Intrinsic capacity

Short-term functional recovery

no changein humans1

1 study
  1. Charlson Comorbidity Index was not clearly linked with short-term functional recovery in humans (not statistically significant).

    “After adjustment for covariates, specific diagnoses such as Endocrine and Respiratory diseases were strong predictors of recovery, whereas CCI was not statistically significant.”

    Humansn = 213

    Predictive Value of Incorporating Principal Diagnosis into CGA for Short-Term Functional Recovery in an ACE Unit: A Retrospective Study

    Clinical interventions in aging

In-hospital mortality

no changein humans1

1 study
  1. Charlson Comorbidity Index was not clearly linked with in-hospital mortality in patients admitted to MICU following RRT within 24 hours of admission (p = 0.102).

    “In contrast, CCI did not correlate with mortality among patients admitted to MICU (p = 0.102).”

    Humansin patients admitted to MICU following RRT within 24 hours of admissionn = 183

    Assessing the Role of Charlson Comorbidity Index in Predicting Mortality Among Patients Requiring Rapid Response Team within 24 Hours of Admission

    AHA Scientific Sessions 2025 abstract

Progression-free survival

no changein humans1HR 1

1 study
  1. Charlson Comorbidity Index showed no clear effect on progression-free survival in humans (metastatic colorectal cancer) (pooled HR = 1.00, 95% CI: 0.89-1.14).

    “No significant difference was observed for PFS (pooled HR = 1.00, 95% CI: 0.89-1.14; I2 = 4.9%).”

    Reviewmetastatic colorectal cancer

    Impact of Comorbidity Burden on Clinical Outcomes in Older Adults With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    Cureus

Postoperative complications

no changein humans1

1 study
  1. Charlson Comorbidity Index showed no clear effect on postoperative complications in humans.

    “CCI was not associated with any of the postoperative complications studied.”

    Review

    Frailty and Postoperative Outcomes Following Endoscopic Endonasal Skull Base Surgery: A Scoping Review

    Ear, nose, & throat journal

All 18

Upstream

3

National Early Warning Score 2

no changein humans1

1 study
  1. National Early Warning Score 2 was not clearly linked with Charlson Comorbidity Index in-hospital cardiac arrest patients.

    “CCI and age did not significantly differ”

    Humansin-hospital cardiac arrest patientsn = 70

    Combining the National Early Warning Score 2 with Frailty Assessment Improves Early Identification of Patients at Risk of In-Hospital Cardiac Arrest

    Preprints.orgPreprint

More on National Early Warning Score 2

Time

no changein humans1

1 study
  1. time was not clearly linked with Charlson Comorbidity Index in humans.

    “There was no statistically significant change in the CCI or the Katz ADL.”

    Humans9-year period

    Are our patients becoming more complex? Trends in comorbidity and functional dependence in General Medicine 2011-2019

    Internal medicine journal

COVID-19

no changein humans1OR 1.12

1 study
  1. COVID-19 was not clearly linked with Charlson Comorbidity Index in humans (geriatric patients readmitted three months after initial admission) (OR 1.12, 95% CI 0.94-1.34).

    “The Covid-19 patients did not have worse health after three months compared to the matched controls according to the CCI (odds ratio, OR[95% confidence interval, CI] = 1.12[0.94-1.34])”

    Humansgeriatric patients readmitted three months after initial admission

    Health progression for Covid-19 survivors hospitalized in geriatric clinics in Sweden

    PloS one

More on COVID-19

Associations

158

Mortality

upin humans155no changein humans2downin humans2+20% oddsOR 1.17–19.5

158 studies
  1. Charlson Comorbidity Index is associated with mortality in humans (sepsis survivors) (Mortality 21%, 38%, 51%, and 67% for Charlson index 0, 1–2, 3–4, and ≥ 5, respectively).

    “with comorbidity burden (21%, 38%, 51%, and 67% for Charlson index 0, 1–2, 3–4, and ≥ 5, respectively; p < 0.0001)”

    Humanssepsis survivorswithin 2 years after hospital dischargen = 237,075

    Sepsis survivors faced high mortality after hospital discharge

    Critical care medicine

  2. Charlson Comorbidity Index is associated with mortality in humans Following cement augmentation for osteoporotic vertebral fractures.

    “Increasing age, higher Charlson Comorbidity Index (CCI), worse baseline Oswestry Disability Index and EuroQol-5Dimensional index were associated with increased mortality”

    HumansFollowing cement augmentation for osteoporotic vertebral fracturesUp to 11 yearsn = 106

    Long-term survival, refracture and reoperation following vertebral augmentation for osteoporotic vertebral fractures: up to an 11-year single-centre cohort

    Brain & spine

  3. Charlson Comorbidity Index is linked with a higher risk of mortality in humans (cardiovascular CICU admissions) (OR 5.11, 95% CI 3.35–7.81).

    “After adjustment for age, sex, and LVEF, CCI remained strongly associated with mortality (CCI≥3 vs 0: OR 5.11, 95% CI 3.35–7.81”

    Humanscardiovascular CICU admissionsn = 4,850

    Comorbidity burden drives hard outcomes in a cardiovascular cardiac ICU cohort

    ESC Congress 2026 abstract

  4. Charlson Comorbidity Index is associated with mortality in humans (hip fracture patients in Greenland) (OR 3.1, 95% CI 1.6–5.9; p = 0.001).

    “Mortality was raised with a worse ASA score 3 (OR = 3.8, 1.9-7.4; p < 0.001) and CCI (OR = 3.1, 1.6-5.9; p = 0.001)”

    Humanship fracture patients in Greenlandn = 262

    Surgery delays were not linked to hip fracture deaths in Greenland

    International journal of circumpolar health

  5. Charlson Comorbidity Index is associated with mortality in humans (proximal humerus fractures; multivariable Cox regression) (HR 1.47, 95% CI 1.25–1.73).

    “higher CCI was independently associated with increased mortality (HR: 1.47, 95% CI: 1.25–1.73; p<0.001)”

    Humansproximal humerus fractures; multivariable Cox regressionn = 261

    Mortality Following Proximal Humerus Fractures in Elderly Patients: A Retrospective Cohort Study of Clinical and Laboratory Predictors

    Geriatric orthopaedic surgery & rehabilitation

  6. Charlson Comorbidity Index is associated with mortality in humans After ventriculoperitoneal shunting for idiopathic normal pressure hydrocephalus (HR 1.27).

    “higher CCI (HR 1.27, p = 0.005) and hospitalization >1 day (HR 3.20, p = 0.001) were independently associated with increased mortality.”

    HumansAfter ventriculoperitoneal shunting for idiopathic normal pressure hydrocephalusMedian follow-up 39.1 months61.9% malesn = 452

    Mortality after ventriculoperitoneal shunting for idiopathic normal pressure hydrocephalus and its clinical predictors

    Journal of the neurological sciences

  7. Charlson Comorbidity Index predicts mortality in humans (colorectal cancer) (AUC 0.686, p = 0.008).

    “Significant discrimination was observed only for colorectal cancer after adding the CCI or ECI to the baseline model (CCI AUC 0.686, p = 0.008; ECI AUC 0.682, p = 0.024).”

    Humanscolorectal cancer

    Performance of Charlson Comorbidity Index and Elixhauser Comorbidity Index to Predict Prognosis Among Cancer Patients

    Journal of Pharmacoepidemiology and Risk Management

  8. Charlson Comorbidity Index is linked with a higher risk of mortality in humans.

    “Higher CCI, presence of ≥ 2 comorbidities, non-orthopedic surgery, and general anesthesia were associated with increased 6-month mortality.”

    Humansn = 106

    Morbidity and predictors of mortality in nonagenarians undergoing emergency surgery

    ˜The œJournal of Latin American geriatric medicine

  9. Charlson Comorbidity Index predicts mortality in humans (CCI score 1, 5-year follow-up) (aHR 1.86).

    “CCI scores of 1 and ≥2 were associated with significantly increased 5-year mortality (aHR 1.86 and 3.30, respectively)”

    HumansCCI score 1, 5-year follow-up

    Comorbidities and infectious episodes in multiple sclerosis patients within general practices in the Netherlands

    Multiple sclerosis and related disorders

  10. Charlson Comorbidity Index is linked with a higher risk of mortality in humans (patients with AAAI and indication for elective repair) (HR 1.2, P < 0.001).

    “CCI hazard ratio [HR] = 1.2, P < 0.001”

    Humanspatients with AAAI and indication for elective repair5-yearn = 424

    Comparative Performance of Six General Comorbidity Indices for Predicting Survival in Patients with Aortoiliac Aneurysms

    Annals of vascular surgery

All 161

In-hospital mortality

upin humans12OR 1.13–2.051

12 studies
  1. Charlson Comorbidity Index is associated with in-hospital mortality in humans (first episode of true bacteremia; multivariable analysis) (aOR 1.74, 95% CI 1.10–2.73).

    “Immunosuppression, greater comorbidity burden, concomitant COVID-19, and an abdominal source of infection were independently associated with higher odds of in-hospital mortality.”

    Humansfirst episode of true bacteremia; multivariable analysisn = 400

    Factors associated with in-hospital mortality in adults ≥ 65 years with bacteremia in a tertiary referral hospital in Manizales, Colombia, 2020–2023

    BMC geriatrics

  2. Charlson Comorbidity Index is linked with a higher risk of in-hospital mortality in humans (OR 1.70, 95% CI 1.17–2.51).

    “CCI was also associated with mortality (OR 1.70, 95% CI 1.17–2.51; p = 0.006)”

    Humansn = 200

    Association between perioperative acute kidney injury and in-hospital mortality in patients aged 80 years and older undergoing hemiarthroplasty for femoral neck fractures: a retrospective cohort study

    BMC geriatrics

  3. Charlson Comorbidity Index predicts in-hospital mortality in patients admitted to CICU following RRT within 24 hours of admission (p = 0.01, R-squared = 0.115).

    “CCI was significantly associated with in-hospital mortality in the CICU with a moderate predictive relationship (p = 0.01, R-squared = 0.115)”

    Humansin patients admitted to CICU following RRT within 24 hours of admissionn = 61

    Assessing the Role of Charlson Comorbidity Index in Predicting Mortality Among Patients Requiring Rapid Response Team within 24 Hours of Admission

    AHA Scientific Sessions 2025 abstract

  4. Charlson Comorbidity Index is linked with a higher risk of in-hospital mortality in humans (undergoing emergency laparotomy with dedicated geriatrician-led perioperative care) (HR 1.38, p = 0.034).

    “Each increment in CCI was associated with increased in-hospital (HR 1.38, p = 0.034)”

    Humansundergoing emergency laparotomy with dedicated geriatrician-led perioperative caren = 114

    Emergency laparotomy in older adults with geriatric medicine input: implications of demographics, frailty and comorbidities on outcomes

    ANZ journal of surgery

  5. Charlson Comorbidity Index predicts in-hospital mortality in humans (hip fracture) (p=0.0001).

    “only the presence of cardiac disease (p=0.0001) and the increase in CCI scores (p=0.0001) were found to have a statistically significant increasing effect on mortality”

    Humanship fracturen = 200

    The role of ASA score and Charlson comorbidity index in predicting in-hospital mortality in geriatric hip fracture patients

    European review for medical and pharmacological sciences

  6. Charlson Comorbidity Index predicts in-hospital mortality in humans (COVID-19 infection) (OR 1.78, 95% CI 1.02-3.11).

    “Significant elevation of in-hospital mortality was found for the high CCI-scores (≥ 5)(OR 1.78, 95% 1.02-3.11)”

    HumansCOVID-19 infectionn = 292

    Performance of the APOP-screener for predicting in-hospital mortality in older COVID-19 patients: a retrospective study

    BMC geriatrics

  7. Charlson Comorbidity Index predicts in-hospital mortality in humans (infective endocarditis) (OR 1.46, 95% CI 1.07-1.99, p = 0.017).

    “CCI ≥ 3 was an independent predictor of in-hospital and 1-year mortality (odds ratio 1.46, 95% confidence interval 1.07−1.99, p = 0.017”

    Humansinfective endocarditisn = 726

    Comorbidity and Prognosis in Octogenarians with Infective Endocarditis

    Journal of clinical medicine

  8. Charlson Comorbidity Index is linked with a higher risk of in-hospital mortality in humans (invasive mechanical ventilation in the emergency department) (OR 1.19; 95% CI 1.02-1.38).

    “Charlson index (OR 1.19; 95% CI 1.02-1.38)”

    Humansinvasive mechanical ventilation in the emergency departmentn = 285

    In-hospital mortality associated factors in elderly patients with invasive mechanical ventilation in the emergency department

    Enfermeria intensiva

  9. Charlson Comorbidity Index is associated with in-hospital mortality in humans (rapid response team activation after major hip surgery) (6.5 [1.8] vs. 5.5 [2.1], p = 0.02).

    “those who died displayed higher mean CCI (6.5 [1.8] vs. 5.5 [2.1], p = 0.02)”

    Humansrapid response team activation after major hip surgery

    Rapid Response Team activation after major hip surgery: patient characteristics and outcomes

    Research SquarePreprint

  10. Charlson Comorbidity Index predicts in-hospital mortality in humans (hospitalized due to COVID-19) (OR 1.13, 95% CI 1.02-1.26).

    “higher Charlson Index score [OR 1.13 (95%CI 1.02-1.26)]”

    Humanshospitalized due to COVID-19n = 499

    Functional, Clinical, and Sociodemographic Variables Associated with Risk of In-Hospital Mortality by COVID-19 in People over 80 Years Old

    The journal of nutrition, health & aging

All 12

Frailty

upin humans11OR 1.52–5.086

11 studies
  1. Charlson Comorbidity Index is associated with frailty in humans (Receiving maintenance hemodialysis; Charlson Comorbidity Index ≥5; multivariate analysis) (CCI ≥5: OR = 5.086; p = 0.030).

    “CCI ≥5 (OR = 5.086; p = 0.030) as independent factors associated with frailty.”

    HumansReceiving maintenance hemodialysis; Charlson Comorbidity Index ≥5; multivariate analysisn = 60

    Independent Factors Associated with Frailty Among Older Adults Undergoing Maintenance Hemodialysis: A Cross-Sectional Study

    Indian Journal of Nephrology

  2. Charlson Comorbidity Index is associated with frailty in patients with sepsis without baseline frailty (aOR 1.27, p < 0.001).

    “higher Charlson Comorbidity Index (per 1-SD increase, aOR, 1.27)”

    Humansin patients with sepsis without baseline frailtyn = 6,336

    In-hospital development of new-onset frailty and discharge outcomes among patients with sepsis: a Korean multicenter registry study

    Journal of intensive care

  3. Charlson Comorbidity Index is associated with frailty in humans (multivariable analysis after LASSO regression).

    “were independent influencing factors for frailty in elderly MHD patients”

    Humansmultivariable analysis after LASSO regressionn = 296

    Development and validation of a frailty assessment model for elderly patients undergoing maintenance hemodialysis

    Medicine

  4. Charlson Comorbidity Index is associated with frailty in humans (colorectal cancer) (OR = 1.936, 95% CI 1.229-3.049).

    “Charlson Comorbidity Index (CCI) score (OR = 1.936, 95% CI 1.229-3.049) as significant predictors of frailty.”

    Humanscolorectal cancer

    Construction and validation of frailty risk prediction model in elderly patients with colorectal cancer

    BMC geriatrics

  5. Charlson Comorbidity Index is associated with frailty in humans (kidney transplant candidates) (OR 2.9 [1.6-54]).

    “higher CCI (>6 OR 2.9 [1.6-54])”

    Humanskidney transplant candidatesn = 1,194

    Frailty Prevalence and Characterization Among Kidney Transplant Candidates in Spain: A Multicenter Study

    Transplant international : official journal of the European Society for Organ Transplantation

  6. Charlson Comorbidity Index predicts frailty in humans (patients undergoing cardiovascular surgery) (β = 0.183).

    “Charlson Comorbidity Index (β = 0.183)”

    Humanspatients undergoing cardiovascular surgeryn = 145

    Predictors of frailty after cardiovascular surgery and the relationship between frailty and postoperative recovery: A cross-sectional study

    Journal of evaluation in clinical practice

  7. Charlson Comorbidity Index is associated with frailty in humans (OR 1.52, 95% CI 1.31-1.76).

    “Frailty was associated with a higher CCI with an OR of 1.52 (95% CI 1.31-1.76).”

    Humans

    Influenza infection is not associated with phenotypical frailty in older patients, a prospective cohort study

    Health science reports

  8. Charlson Comorbidity Index is associated with frailty in humans (hospitalized geriatric inpatients) (p < 0.05).

    “All four indices were associated with frailty and polypharmacy(p < 0.05).”

    Humanshospitalized geriatric inpatientsn = 366

    Predictivity of the comorbidity indices for geriatric syndromes

    BMC geriatrics

  9. Frailty is associated with Charlson Comorbidity Index in humans (patients with vascular disease; frailty defined by grip strength) (OR 1.86, 95% CI 1.34–2.57).

    “Frailty was associated with CCI (odds ratio, 1.86; 95% confidence interval, 1.34-2.57; P = .0002) in the multivariable model.”

    Humanspatients with vascular disease; frailty defined by grip strengthn = 311

    Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia

    Journal of vascular surgery

  10. Charlson Comorbidity Index is associated with frailty in humans (end-stage renal disease; Charlson comorbidity index score ≥5) (OR 2.6, 95% CI 1.0–6.6).

    “a Charlson comorbidity index score of ≥5 (OR 2.6, 95 % CI 1.0-6.6) were associated with frailty.”

    Humansend-stage renal disease; Charlson comorbidity index score ≥5n = 95

    High prevalence of frailty in end-stage renal disease

    International urology and nephrology

All 11

1-year mortality

upin humans6HR 1.34–1.39

6 studies
  1. Charlson Comorbidity Index is associated with 1-year mortality in humans (fragility fracture of the pelvis) (adjusted odds ratio 2.55, 95% confidence interval 1.43-7.21).

    “the updated Charlson Comorbidity Index score (adjusted odds ratio 2.55, 95% confidence interval 1.43-7.21; p”

    Humansfragility fracture of the pelvis1-yearn = 46

    Association between the updated Charlson comorbidity index and 1-year mortality after fragility fracture of the pelvis: A prospective observational study

    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

  2. Charlson Comorbidity Index is associated with 1-year mortality in humans following revision total hip arthroplasty for periprosthetic hip fractures (1.70 ± 1.49 vs. 0.80 ± 1.57; p = 0.02).

    “Patient- (higher Charlson Comorbidity Index [CCI] 1.70 ± 1.49 vs. 0.80 ± 1.57, p = 0.02) and surgical- (dislocation post-rTHA - 30%, [OR 4.8] p = 0.03) factors were associated with 1-year mortality.”

    Humansfollowing revision total hip arthroplasty for periprosthetic hip fractures1 year62% femalesn = 96

    Dislocation is associated with increased mortality following revision total hip arthroplasty for periprosthetic hip fractures

    Hip international : the journal of clinical and experimental research on hip pathology and therapy

  3. Charlson Comorbidity Index predicts 1-year mortality in humans following acute exacerbation of chronic obstructive pulmonary disease (AUC 0.714).

    “revealed an AUC of the CCI and CCI (Quan) models of 0.714”

    Humansfollowing acute exacerbation of chronic obstructive pulmonary diseasen = 87,271

    Predictive ability of the COPD-specific comorbidity test (COTE) score versus the Charlson comorbidity index (CCI) in patients with COPD

    BMJ open respiratory research

  4. Charlson Comorbidity Index is linked with a higher risk of 1-year mortality in humans (undergoing emergency laparotomy with dedicated geriatrician-led perioperative care) (HR 1.39, p = 0.006).

    “and 1-year (HR 1.39, p = 0.006) mortality”

    Humansundergoing emergency laparotomy with dedicated geriatrician-led perioperative caren = 114

    Emergency laparotomy in older adults with geriatric medicine input: implications of demographics, frailty and comorbidities on outcomes

    ANZ journal of surgery

  5. Charlson Comorbidity Index predicts 1-year mortality in humans (infective endocarditis) (HR 1.34, 95% CI 1.08-1.66, p = 0.007).

    “hazard ratio 1.34, 95% confidence interval 1.08−1.66, p = 0.007”

    Humansinfective endocarditis1 yearn = 726

    Comorbidity and Prognosis in Octogenarians with Infective Endocarditis

    Journal of clinical medicine

  6. Charlson Comorbidity Index is linked with a higher risk of 1-year mortality in humans (free flap surgery) (odds ratio, 5.1 [95% CI, 1.4-18.6]).

    “Charlson Comorbidity Index ≥2 was associated with an increased risk of 1-year mortality (odds ratio, 5.1 [95% CI, 1.4-18.6]).”

    Humansfree flap surgeryn = 50

    Postoperative and 1-Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

One-year mortality

upin humans5HR 3.24

5 studies
  1. Charlson Comorbidity Index is associated with one-year mortality in humans (Proximal humeral fracture).

    “Male sex, older age, higher CCI, unmarried status, and nursing home residency were associated with increased mortality.”

    HumansProximal humeral fractureOne year

    Mortality and healthcare utilization after proximal humeral fractures in patients aged 65 years and older: a register-based cohort study

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

  2. Charlson Comorbidity Index predicts one-year mortality in humans (Hip fracture with at least two major comorbidities; CCI ≥6).

    “independent predictors of one-year mortality were age >80 years (p=0.002), male gender (p=0.009), CCI ≥6 (p<0.001)”

    HumansHip fracture with at least two major comorbidities; CCI ≥612 monthsn = 138

    Functional Outcomes and Mortality Predictors in Geriatric Hip Fracture Patients with Multiple Comorbidities: A One-Year Study at a Tertiary Care Centre in Western Gujarat

    International Journal of Current Pharmaceutical Review and Research

  3. Charlson Comorbidity Index is associated with one-year mortality in humans (geriatric pelvic ring injuries).

    “The overall mortality was 8.9% (n = 8) and was significantly associated with the CCI.”

    Humansgeriatric pelvic ring injuriesone-yearn = 90

    Does operative treatment of geriatric pelvic ring injuries lead to a high risk of one-year mortality?

    Injury

  4. Charlson Comorbidity Index is linked with a higher risk of one-year mortality in humans following hip fracture surgery (HR=3.24, 95%CI:1.75-6.03).

    “Charlson comorbidity index ≥ 3 (HR=3.24, 95%CI:1.75-6.03, P<0.001)”

    Humansfollowing hip fracture surgeryn = 450

    Analysis of factors related to one-year mortality in elderly patients following hip fracture surgery

    Zhonghua yi xue za zhi

  5. Charlson Comorbidity Index predicts one-year mortality in humans Following laterally based locked plating of a low-energy distal femur fracture.

    “Predictors of one year mortality included older age, higher Charlson Comorbidity Index (CCI), and delay to surgery greater than 2days (p<0.001).”

    HumansFollowing laterally based locked plating of a low-energy distal femur fracturen = 176

    Geriatric distal femur fracture: Are we underestimating the rate of local and systemic complications?

    Injury

Survival

downin humans3no changein humans1

4 studies
  1. Charlson Comorbidity Index predicts survival in humans (patients with AAAI and indication for elective repair).

    “without significant differences in their predictive performance”

    Humanspatients with AAAI and indication for elective repair5-yearn = 424

    Comparative Performance of Six General Comorbidity Indices for Predicting Survival in Patients with Aortoiliac Aneurysms

    Annals of vascular surgery

  2. Charlson Comorbidity Index is associated with survival in humans.

    “The ASA score and age-adjusted Charlson Comorbidity Score were also lower among survivors”

    Humans5 yearsn = 103

    Predictors of long- term survival after pelvic ring fractures in geriatric patients - five-year results of a prospective observational study of 134 patients

    European journal of trauma and emergency surgery : official publication of the European Trauma Society

  3. Charlson Comorbidity Index is associated with survival in humans (polytraumatized patients) (p = 0.001).

    “CCI scores > 2 points (p = 0.001) were found to have a significant influence on the late-phase survival of polytraumatized patients.”

    Humanspolytraumatized patientsn = 173

    Red blood cell distribution width and Charlson comorbidity index help to identify frail polytraumatized patients : Experiences from a level I trauma center

    Wiener klinische Wochenschrift

  4. Charlson Comorbidity Index predicts survival in humans (>13.3, 9.4 and 4.3 years).

    “men age 65 to 69 years with Charlson scores 2, 3 and 4+ had an observed median survival greater than 13.3, 9.4 and 4.3 years, respectively.”

    Humansmales

    Limitations of the National Comprehensive Cancer Network® (NCCN®) Guidelines for Prediction of Limited Life Expectancy in Men with Prostate Cancer

    The Journal of urology

Overall survival

downin humans2upin humans2HR 1.19

4 studies
  1. Charlson Comorbidity Index is associated with overall survival in humans (primary breast cancer treated with upfront surgery) (p = 0.012).

    “worse OS was associated with older age or more comorbidities as measured by the Charlson Comorbidity Index (CCI) (p < 0.001 and p = 0.012, respectively).”

    Humansprimary breast cancer treated with upfront surgeryfemalesn = 553

    De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers

    Current oncology (Toronto, Ont.)

  2. Charlson Comorbidity Index is associated with overall survival in humans (early stage (I or II) lung cancer).

    “Across all age groups, the 5-year OS was higher for those with fewer comorbidities”

    Humansearly stage (I or II) lung cancern = 6,401

    Brief Report: Evaluating Early Stage Lung Cancer Survival Patterns in Patients at the Upper Age Limit for Lung Cancer Screening

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

  3. Charlson Comorbidity Index predicts overall survival in humans (non-metastatic prostate cancer) (c-index = 0.763).

    “Regarding the prediction of 5-year overall survival, CCI (c-index = 0.763) slightly higher predictive performance than ECI (0.758), NCI (0.755), and C3 (0.754).”

    Humansnon-metastatic prostate cancer5-yearmalesn = 11,470

    Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer

    Cancer epidemiology

  4. Charlson Comorbidity Index is associated with overall survival in humans (metastatic colorectal cancer) (pooled HR = 1.19, 95% CI: 1.02-1.39).

    “Higher comorbidity burden was significantly associated with worse OS (pooled HR = 1.19, 95% CI: 1.02-1.39; I2 = 84.1%).”

    Reviewmetastatic colorectal cancern = 16,736

    Impact of Comorbidity Burden on Clinical Outcomes in Older Adults With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    Cureus

Length of stay

upin humans3

3 studies
  1. Charlson Comorbidity Index is associated with length of stay in humans (cardiovascular CICU admissions) (ρ = 0.33).

    “CCI correlated with hospital LOS (ρ = 0.33; p<0.001)”

    Humanscardiovascular CICU admissionsn = 4,850

    Comorbidity burden drives hard outcomes in a cardiovascular cardiac ICU cohort

    ESC Congress 2026 abstract

  2. Charlson Comorbidity Index is associated with length of stay in humans (degenerative spinal diseases undergoing elective spinal surgery).

    “LOS was significantly associated with surgical invasiveness and CCI.”

    Humansdegenerative spinal diseases undergoing elective spinal surgeryn = 85

    Central Sarcopenia, Frailty and Comorbidity as Predictor of Surgical Outcome in Elderly Patients with Degenerative Spine Disease

    Journal of Korean Neurosurgical Society

  3. Charlson Comorbidity Index predicts length of stay in humans (Immobile ischemic stroke patients; CCI score ≥3 compared with a low CCI score).

    “A high CCI=3+ score was an effective predictor of a high risk of longer LoS and death compared with a low CCI score”

    HumansImmobile ischemic stroke patients; CCI score ≥3 compared with a low CCI scoren = 5,114

    Length of Stay, Hospital Costs and Mortality Associated With Comorbidity According to the Charlson Comorbidity Index in Immobile Patients After Ischemic Stroke in China: A National Study

    International journal of health policy and management

Other-cause mortality

upin humans3HR 1.88–3.99

3 studies
  1. Charlson Comorbidity Index predicts other-cause mortality in humans (stages I-III breast cancer) (0.65 (95%-CI 0.64-0.65) vs 0.64 (95%-CI 0.64-0.65)).

    “c-statistics of the Charlson index and comorbidity count were similar (0.65 (95%-CI 0.64-0.65) and 0.64 (95%-CI 0.64-0.65))”

    Humansstages I-III breast cancer5 yearsfemalesn = 7,511

    Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity

    Cancers

  2. Charlson Comorbidity Index predicts other-cause mortality in humans (Index 3 or greater: HR 3.99, 95% CI 1.57–10.1).

    “as well as Charlson comorbidity indexes 1 (HR 1.45, 95% CI 1.00-2.09) and 3 or greater (HR 3.99, 95% CI 1.57-10.1).”

    HumansCharlson comorbidity index 3 or greater; prostate cancer treated with radical prostatectomy10 yearsmales

    Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy

    The Journal of urology

  3. Charlson Comorbidity Index predicts other-cause mortality in humans (patients with prostate cancer) (HR 1.88, 95% CI 1.61-2.21).

    “and 1.88 (95 % CI 1.61-2.21) for other-cause mortality”

    Reviewpatients with prostate cancern = 457,256

    Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis

    Heliyon

30-day mortality

upin humans2OR 1.25

2 studies
  1. Charlson Comorbidity Index predicts 30-day mortality in humans (lower gastrointestinal bleeding) (OR 1.25 per-point, 95% CI 1.14-1.37).

    “Charlson Comorbidity Index (OR = 1.25 per-point, 95% CI 1.14-1.37) were independently associated with 30-day mortality (p < 0.001)”

    Humanslower gastrointestinal bleedingn = 1,058

    Age-related differences in the presentation, management, and outcomes of lower gastrointestinal bleeding: a retrospective multinational cohort study

    The Lancet regional health. Europe

  2. Charlson Comorbidity Index is associated with 30-day mortality in humans following hip surgery.

    “Advanced age and higher Charlson Comorbidity Index scores were significant associated with 30-dat mortality following hip surgery.”

    Humansfollowing hip surgery30 daysn = 1,221

    30-day morbidity and mortality after hip surgery - A single-centre study

    JPMA. The Journal of the Pakistan Medical Association

Handgrip strength

upin humans1

1 study
  1. Charlson Comorbidity Index is associated with handgrip strength in humans (COPD) (p=0.01).

    “A higher Charlson index correlated with a positive delta, while a negative delta correlated with a lower Charlson index (p=0.01).”

    Human trialCOPD

    Handgrip Evaluation Before and After Pulmonary Rehabilitation Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Cureus

More on Handgrip strength

All 158

Latest

Dec 2025: 39Jan 2026: 31Feb 2026: 31Mar 2026: 35Apr 2026: 26May 2026: 34Jun 2026: 36Jul 2026: 40Aug 2026: 28Sep 2026: 32Oct 2026: 54Nov 2026: 34420 papers in 12 months
Journal of Critical Care

Age and frailty linked to different intensive care outcomes

Among older intensive care patients, 50.2% of kidney injury survivors recovered by discharge; frailty and other illnesses were linked to lower recovery.Among older intensive care patients, 50.2% of kidney injury survivors recovered by discharge; frailty and other illnesses were linked to lower recovery.

Cohort · 2,387 peoplePopulations
Frontiers in Nutrition

Enhanced swallowing care had some early benefits in older adults

In a randomized trial, 600 hospitalized adults with swallowing difficulties received one of two care programs; most differences were no longer evident at six months.In a randomized trial, 600 hospitalized adults with swallowing difficulties received one of two care programs; most differences were no longer evident at six months.

Accepted, not yet published: randomized trial · 600 peopleInterventions

See all 2,033 papers on Charlson Comorbidity Index